Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice
- 13 November 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (52) , 7945-7956
- https://doi.org/10.1038/sj.onc.1205956
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 36 references indexed in Scilit:
- The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculatureGenes & Development, 2002
- In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effectsGenes & Development, 2001
- Cancer chemoprevention through interruption of multistage carcinogenesisEuropean Journal Of Cancer, 2000
- Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in MiceScience, 1999
- The role of thrombospondin‐1 in tumor progression and angiogenesisBioEssays, 1996
- Concepts in multistage carcinogenesisCritical Reviews in Oncology/Hematology, 1995
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progressionBreast Cancer Research and Treatment, 1995
- Multistage carcinogenesis in mouse skinPharmacology & Therapeutics, 1992
- Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma.Journal of Clinical Investigation, 1991